StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -0.39 CAD. The highest annual figure on record is -0.39 CAD in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-0.39 CAD–
FY2024Dec 31, 2024-0.51 CAD–
FY2023Dec 31, 2023-0.44 CAD–
FY2022Dec 31, 2022-0.49 CAD–
FY2021Dec 31, 2021-0.73 CAD–
FY2020Dec 31, 2020-0.69 CAD–

More Cardiol Therapeutics figures

See a number that looks wrong?